11.05.2015 • NewsAir ProductsappointmentDow Chemicals

Peter Wilkes New Managing Director of Biesterfeld Spezialchemie

Peter Wilkes, Managing Director of Biesterfeld Spezialchemie since May 2015
Peter Wilkes, Managing Director of Biesterfeld Spezialchemie since May 2015

Peter Wilkes (54) has been appointed as Managing Director of Biesterfeld Spezialchemie next to Dr. Nicole Hamelau with effect of May 1, 2015. Wilkes is responsible for the further strategic development and the operative business of the company and its subsidiaries. He is the successor of Thomas Arnold, who assumed the position of CEO of Biesterfeld AG on April 1, 2015. Wilkes holds a degree in economics and earned a Master of Business Administration from the University of Chicago, Illinois, USA. With previous management positions at companies like Dow Chemicals, Air Products and Chemicals, and Kolb, Peter Wilkes has gained over 25 years of international experience in the increasingly globally oriented specialty chemical industry.

„I am looking forward to this new challenge", commented Peter Wilkes the appointment. „Biesterfeld is a very successful company with a long tradition and a strong potential for future growth. Together with our suppliers and customers we would like to shape this future."

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.